Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01579942 · ClinicalTrials.gov registry record
Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 70
- Enrollment target
NCT01579942: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT01579942 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01579942 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The investigators are doing this study to find out if they can use electroencephalographic (EEG) recordings, which measure brain waves, to predict response to antidepressant treatments, as well as to distinguish patients who have depression from those who do not. In particular the investigators want to test the usefulness of a new type of analysis of EEG recordings called brain network activation or BNA. BNA allows to identify patterns of activation in brain networks and to track their changes over time.
Primary Outcome
The investogators will make a comparison of Functional networks of brain activity (BNA™) in subjects with MDD and healthy individuals measured using analysis of EEG Event Related Potential (ERP) data \[ Time Frame: Baseline, 1 week after the first dose of antidepressant treatment, end of the treatment phase\].
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-04 |
Why NCT01579942 stopped before completion
NCT01579942 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01579942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01579942 about?
NCT01579942 is a clinical study titled "Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression". The investigators are doing this study to find out if they can use electroencephalographic (EEG) recordings, which measure brain waves, to predict response to antidepressant treatments, as well as to distinguish patients who have depression from those who do not. In particular the investigators want...
What is the current status of trial NCT01579942?
This trial is currently terminated. The enrollment target is 70 participants. The study started on 2012-04.
Who is sponsoring clinical trial NCT01579942?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia